Aβ species, including IsoAsp23 Aβ, in Iowa-type familial cerebral amyloid angiopathy

Acta Neuropathologica

Volumn 105, Issue 3, 2003, Pages 252-258

  Shin, Youngah ^a   Cho, Hyun Soon ^a   Fukumoto, Hiroaki ^a   Shimizu, Takahiko ^b   Shirasawa, Takuji ^b   Greenberg, Steven M ^a   Rebeck, G William ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Alzheimer's disease; Isomerization; Mutation; Vascular dementia

Indexed keywords

AMYLOID BETA PROTEIN; ASPARAGINE; ASPARTIC ACID; BRAIN EXTRACT; MONOCLONAL ANTIBODY; ANTIBODY; DIAGNOSTIC AGENT; ISOASPARTIC ACID;

AGED; ARTICLE; BRAIN BLOOD VESSEL; BRAIN REGION; BRAIN TISSUE; CASE REPORT; DEMENTIA; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY STUDY; GENE MUTATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; ONSET AGE; PRIORITY JOURNAL; UNITED STATES; VASCULAR AMYLOIDOSIS; WILD TYPE; BLOOD VESSEL; BRAIN; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; MUTATION; PATHOLOGY; VASCULARIZATION;

AMYLOID BETA-PROTEIN; ANTIBODIES; BLOOD VESSELS; BRAIN; CEREBRAL AMYLOID ANGIOPATHY, FAMILIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; IOWA; ISOASPARTIC ACID; MUTATION;

EID: 0037775901     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-002-0639-0     Document Type: Article

References (47)

1. Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM (1998) Progression of cerebral amyloid angiopathy. Accumulation of Aβ40 in already affected vessels. J Neuropathol Exp Neurol 57:353-359
2. Asami-Odaka A, Ishibashi Y, Kikuchi T, Kitada C, Suzuki N (1995) Long amyloid β-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry 34:10272-10278
3. Castano EM, Prelli F, Soto C, Beavis R, Matsubara E, Shoji M, Frangione B (1996) The length of amyloid-β in hereditary cerebral hemorrhage with amyloidosis, Dutch type. J Biol Chem 271:32185-32191
4. De Jonghe C, Zehr C, Yager D, Prada C-M, Younkin S, Hendriks L, Van Broeckhoven C, Eckman CB (1998) Flemish and Dutch mutations in amyloid β precursor protein have different efffects on amyloid β secretion. Neurobiol Dis 5:281-286
5. Dermaut B, Kumar-Singh S, De Jonghe C, Cruts M, Lofgren A, Lubke U, Cras P, Dom R, De Deyn PP, Martin JJ, Van Broeckhoven C (2001) Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation. Brain 124:2383-2392
6. 6 Fraser PE, Nguyen JT, Surewicz WK, Kirschner DA (1991) pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J 60:1190-1201
7. Fraser PE, Nguyen JT, Inouye H, Surewicz WK, Selkoe DJ, Podlisny MB, Kirschner DA (1992) Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein. Biochemistry 31:10716-10723
8. Fraser PE, McLachlan DR, Surewicz WK, Mizzen CA, Snow AD, Nguyen JT, Kirschner DA (1994) Conformation and fibrillogenesis of Alzheimer Aβ peptides with selected substitution of charged residues. J Mol Biol 244:64-73
9. Fukuda H, Shimizu T, Nakajima M, Mori H, Shirasawa T (1999) Synthesis, aggregation, and neurotoxicity of the Alzheimer's Abeta 1-42 amyloid peptide and its isoaspartyl isomers. Bioorg Med Chem Lett 9:953-956
10. Fukumoto H, Tomita T, Matsunaga H, Ishibashi Y, Saido TC, Iwatsubo T (1999) Primary cultures of neuronal and non-neuronal rat brain cells secrete similar proportions of amyloid β peptides ending at Aβ40 and Aβ42. NeuroReport 10:2965-2969
11. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890
12. Grabowski TJ, Cho HS, Vonsattel JPG, Rebeck GW, Greenberg SM (2001) A novel APP mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 49:697-705
13. Gravina SA, Ho L, Eckman CB, Long KE, Otvos LJ, Younkin LH, Suzuki N, Younkin SG (1995) Amyloid beta protein (Abeta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Abeta 40 or Abeta 42(43). J Biol Chem 270:7013-7016
14. Haass C, Hung AY, Selkoe DJ, Teplow DB (1994) Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor. J Biol Chem 269:17741-17748
15. Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12:383-388
16. Hendriks L, Duijn CM van, Cras P, Cruts M, Van Hul W, Harskamp F van, Warren A, McInnis MG, Antonarakis SE, Martin JJ, Hofman A, Van Broeckhoven C (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1:218-21
17. Holton JL, Ghiso J, Lashley T, Rostagno A, Guerin CJ, Gibb G, Houlden H, Ayling H, Martinian L, Anderton BH, Wood NW, Vidal R, Plant G, Frangione B, Revesz T (2001) Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol 158:515-526
18. Holton JL, Lashley T, Ghiso J, Braendgaard H, Vidal R, Guerin CJ, Gibb G, Hanger DP, Rostagno A, Anderton BH, Strand C, Ayling H, Plant G, Frangione B, Bojsen-Moller M, Revesz T (2002) Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta. J Neuropathol Exp Neurol 61:254-267
19. Jarrett JT, Berger EP, Lansbury PTJ (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32:4693-4697
20. Johnson-Wood K, Lee M, Motter R, Hu K, Gordon G, Barbour R, Khan K, Gordon M, Tan H, Games D, Lieberburg I, Schenk D, Seubert P, McConlogue L (1997) Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci USA 94:1550-1555
21. Kirkitadze MD, Condron MM, Teplow DB (2001) Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis. J Mol Biol 312:1103-1119
22. Kirschner DA, Inouye H, Duffy LK, Sinclair A, Lind M, Selkoe DJ (1987) Synthetic peptide homologous to β protein from Alzheimer disease forms amyloid-like fibers in vitro. Proc Natl Acad Sci USA 84:6953-6957
23. Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ (1996) Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis 3:16-32
24. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, Duinen SG van, Bots GTAM, Luyendijk W, Frangione B (1990) Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124-1126
25. Mann DMA, Pickering-Brown SM, Takeuchi A, Iwatsubo T (2001) Amyloid angiopathy and variability in amyloid β deposition is determined by mutation position in presenilin-1-linked Alzheimer disease. Am J Pathol 158:2165-2175
26. Mead S, James-Galton M, Revesz T, Doshi RB, Harwood G, Pan EL, Ghiso J, Frangione B, Plant G (2000) Familial British dementia with amyloid angiopathy; early clinical, neuropsychological and imaging findings. Brain 123:975-991
27. Melchor JP, McVoy L, Van Nostrand WE (2000) Charge alterations of E22 enhance the pathogenic properties of the amyloid β-protein. J Neurochem 74:2209-2212
28. Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 301:41-52
29. Miravelle L, Tokuda T, Chiarle R, Giaccone G, Bugiani O, Tagliavini F, Frangione B, Ghiso J (2000) Substitutions at codon 22 of Alzheimer's Abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J Biol Chem 275:27110-27116
30. Monro OR, Mackic JB, Yamada S, Segal MB, Ghiso J, Maurer C, Calero M, Frangione B, Zlokovic BV (2002) Substitution at codon 22 reduces clearance of Alzheimer's amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol Aging 23:405-412
31. Murakami K, Irie K, Morimoto A, Ohigashi H, Shindo M, Nagao M, Shimizu T, Shirasawa T (2002) Synthesis, aggregation, neurotoxicity, and secondary structure of various Aβ1-42 mutants of familial Alzheimer's disease at positions 21-23. Biochem Biophys Res Commun 294:5-10
32. Naslund J, Schierhorn A, Hellman U, Lannfelt L, Roses AD, Tjernberg LO, Silberring J, Gandy SE, Winblad B, Greengard P, Nordstedt C, Terenius L (1994) Relative abundance of Alzheimer Aβ amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci USA 91:8378-8382
33. Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, Naslund J, Lannfelt L (2001) The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation. Nat Neurosci 4:887-893
34. Selkoe DJ (1994) Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 10:373-403
35. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV (2000) Clearance of Alzheimer's amyloid-β(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106:1489-1499
36. Shimizu T, Watanabe A, Ogawara M, Mori H, Shirasawa T (2000) Isoaspartate formation and neurodegeneration in Alzheimer's disease. Arch Biochem Biophys 381:225-234
37. Shimizu T, Fukuda H, Murayama S, Izumiyama N, Shirasawa T (2002) Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease. J Neurosci Res (in press)
38. Shinkai Y, Yoshimura M, Ito Y, Odaka A, Suzuki N, Yanagisawa K, Ihara Y (1995) Amyloid β-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels. Ann Neurol 38:421-428
39. Singleton AB, Hall R, Ballard CG, Perry RH, Xuereb JH, Rubinsztein DC, Tysoe C, Matthews P, Cordell B, Kumar-Singh S, De Jonghe C, Cruts M, Van Broeckhoven C, Morris CM (2000) Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation. Brain 123: 2467-2474
40. Sinha S, Lieberburg I (1999) Cellular mechanisms of β-amyloid production and secretion. Proc Natl Acad Sci USA 96: 11049-11053
41. Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C, Ihara Y (1994) High tissue content of soluble β1-40 is linked to cerebral amyloid angiopathy. Am J Pathol 145:452-460
42. Tagliavini F, Rossi G, Padovani A, Magoni M, Andora G, Sgarzi M, Bizzi A, Savioardo M, Carella F, Morbin M, Giaccone G, Bugiani O (1999) A new βPP mutation related to hereditary cerebral haemorrhage. Alzheimer Rep 2:S28
43. Thal DR, Rub U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K, Braak E, Braak H (2000) Sequence of Aβ-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59:733-748
44. Tjernberg LO, Callaway DJE, Tjernberg A, Hahne S, Lilliehook C, Terenius L, Thyberg J, Nordstedt C (1999) A molecular model of Alzheimer amyloid β-peptide fibril formation. J Biol Chem 274:12619-12625
45. Tomiyama T, Asano S, Furiya Y, Shirasawa T, Endo N, Mori H (1994) Racemization and Asp23 residue affects the aggregation properties of Alzheimer amyloid β protein analogues. J Biol Chem 269:10205-10208
46. Urmoneit B, Prikulis I, Wihl G, D'Urso D, Frank R, Heeren J, Beisiegel U, Prior R (1997) Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy. Lab Invest 77:157-166
47. Van Nostrand WE, Melchor JP, Cho HS, Greenebrg SM, Rebeck GW (2001) Pathogenic effects of D23N Iowa mutant amyloid β-protein. J Biol Chem 276:32860-32866